31May 2017

MANAGEMENT OF DRUG-INDUCED GINGIVAL OVERGROWTH ASSOCIATED WITH THE USE OF AMLODIPINE- A CASE REPORT.

  • PG student, Department of Periodontology, Maharana Pratap College of Dentistry & Research Centre, Gwalior.
  • Professor and Head, Department of Periodontology, Maharana Pratap College of Dentistry & Research Centre, Gwalior.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Gingival overgrowth is well known side effect of calcium channel blocker, anti convulsant drugs and immunosuppressants which adversely affect speech, mastication, tooth eruption, and esthetics. Although Nifedipine is a calcium channel blocker which is commonly reported to result in drug-induced gingival overgrowth. This report outlines a case of gingival overgrowth induced by Amlodipine (a calcium channel blocker less frequently reported to cause gingival hyperplasia), exacerbated by the presence of plaque. The case of drug induced gingival enlargement should be treated in a step-wise manner, including consultation with the patient?s physician, substitution of the drug, nonsurgical therapy, surgical therapy (if needed), and supportive periodontal therapy after every 3 months. In this case non surgical therapy and drug substitution showed significant result and no recurrences occurred 3 months postoperatively.

  1. Dongari-Bagtzoglou A, Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol. 2004;75(10):1424-1431.
  2. Butler RT, Kalkwarf KL, Kaldhal WB. Drug-induced gingival hyperplasia: phenytoin, cyclosporine and nifedipine. J Am Dent Assoc. 1987;114(1):56-60.
  3. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol. 1996;23:165?75.
  4. Mccullough, K. (ed.). Dorland?s Pocket Medical Dictionary. W.B. Saunders Company; Sydney, 1982.
  5. Jose J, Santhosh YL, Naveen MR, Kumar V. Case report of amlodipine induced gingival hyperplasia ? late onset at a low dose. Asian J Pharm Clin Res 2011; 4: 65?6.
  6. Lafzi A, Farahani RM, Shoja MA. Amlodipine induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal 2006; 11: 480?2.
  7. Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc 1996; 73: 1196?9.
  8. Sucu M, Yuce M, Davatoglu V. Amlodipine induced massive gingival Can Fam Physician 2011; 57: 436?7.
  9. Prisant LM, hermanw. Calcium channel blocker induced gingival overgrowth. J Clin Hypertens 2002; 4: 310?1.
  10. Dongari-Baqtzoglou A, Research, Science and therapy committee, American Academy of Periodontology, Academy Report. Drug-Associated Gingival Enlargement. J Periodontol. 2004; 75:1424-31.

[Rachna Jindal and Sudhir S Patil. (2017); MANAGEMENT OF DRUG-INDUCED GINGIVAL OVERGROWTH ASSOCIATED WITH THE USE OF AMLODIPINE- A CASE REPORT. Int. J. of Adv. Res. 5 (May). 2232-2235] (ISSN 2320-5407). www.journalijar.com

Rachna Jindal
post graduate student

DOI:

Article DOI: 10.21474/IJAR01/4372      
DOI URL: https://dx.doi.org/10.21474/IJAR01/4372

Download Full Paper

Download PDF No. of Downloads: 20 | No. of Views: 105